Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishment and Characterization of a Novel Pleuropulmonary Blastoma Cell Line.
Kato K, Goto H, Tanaka M, Suzuki T, Toyoda Y, Shinkai M, Kitagawa N, Nishi T, Kigasawa H, Kurosawa K, Aida N, Yoshimi A, Noda A, Ito Y, Seki M, Takita J, Nagahara N, Tsuchida M, Tanaka Y. Kato K, et al. Among authors: tsuchida m. Genes Chromosomes Cancer. 2024 Oct;63(10):e23276. doi: 10.1002/gcc.23276. Genes Chromosomes Cancer. 2024. PMID: 39400393
Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitors.
Kobayashi K, Sakano S, Matsumoto H, Yamamoto M, Tsuchida M, Tei Y, Nagao K, Oba K, Kitahara S, Yano S, Yoshihiro S, Yamamoto Y, Ohmi C, Komatsu H, Misumi T, Akao J, Shiraishi K. Kobayashi K, et al. Among authors: tsuchida m. Jpn J Clin Oncol. 2024 Oct 7:hyae137. doi: 10.1093/jjco/hyae137. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39373462
Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching.
Kobayashi K, Matsumoto H, Sakano S, Yamamoto M, Tsuchida M, Tei Y, Nagao K, Oba K, Kitahara S, Yano S, Yoshihiro S, Yamamoto Y, Ohmi C, Komatsu H, Misumi T, Akao J, Shiraishi K. Kobayashi K, et al. Among authors: tsuchida m. Clin Genitourin Cancer. 2024 Dec;22(6):102212. doi: 10.1016/j.clgc.2024.102212. Epub 2024 Aug 23. Clin Genitourin Cancer. 2024. PMID: 39270620
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.
Kato K, Nagai JI, Goto H, Shinkai M, Kitagawa N, Toyoda Y, Nishi T, Kigasawa H, Tanaka M, Kurosawa K, Ito Y, Haruta M, Kamijo T, Yoshimi A, Tsuchida M, Nagahara N, Tanaka Y. Kato K, et al. Among authors: tsuchida m. Hum Cell. 2024 Sep;37(5):1602-1609. doi: 10.1007/s13577-024-01106-6. Epub 2024 Jul 30. Hum Cell. 2024. PMID: 39080217
567 results